About Creative Bioarray
Frequently asked questions
Yes. Its official cosmetics pages describe in vitro and ex vivo efficacy and safety studies for active ingredients and cosmetic formulations.
Published areas include hydration, barrier function, pigmentation, anti-aging, anti-wrinkle, anti-acne and UV-protection effects.
The website lists reconstructed human epidermis, full-thickness skin, pigmented skin, disease models and ex vivo skin explants.
Yes. The company states that it develops custom experimental services for special efficacy or safety-testing requirements.
Yes. Its official pages state that products and services are for research use only and not for any other purpose.
More details about Creative Bioarray
Services
Assess formula composition, physical properties, microbiological quality, stability and packaging compatibility, alongside laboratory hazards, human tolerance and expert safety assessment. Quality results and safety evidence answer different questions; neither should be inferred from the other.
Evaluate ingredient activity and product benefits using methods suited to the question, including chemical and optical assays, cell and tissue models, and human outcome studies. Laboratory mechanisms support development but do not automatically establish visible benefits in people. Human results apply to the tested product, population, endpoint and protocol.
Plan supporting evidence, organise results and review marketing claims.
Claims substantiation connects cosmetic benefit statements with appropriate evidence and review. This category covers study design, scientific literature assessment, evidence dossiers, advertising claim review and marketing-content review, with each service addressing a different part of the same evidence-to-communication process.
Integrated hazard and exposure interpretation by suitable experts.
Integrated toxicological safety assessment interprets hazard and exposure. It is not itself a human tolerance experiment or the complete EU CPSR deliverable.
Laboratory irritation endpoints using an appropriate model.
Complementary evidence on sensitisation potential, with scope and exposure considered.
Epidermal lipids, differentiation and water-handling mechanisms.
Pigment production, regulation and transfer endpoints.
Collagen, elastin, matrix turnover, glycation or senescence endpoints.
Experimental UV responses, not a substitute for validated SPF measurement.

